Mar. 11 at 8:12 PM
$CAPR
"The Hangman"
"When the Hangman catches you... you hang"
If you're a Quentin Tarantino fan, you already know what I'm talking about. This is in reference to what I posted last October -> https://stocktwits.com/LineBacker04/message/630627298.
At that time, I was expecting Vinay to be gone in a matter of months, but governments tend to be slower than what we expect. This should be a big boost to stocks like
$REPL and others who were trying to get approvals in the rare disease space based on "plausible mechanism of action" but
$CAPR is now in a completely different situation where there isn't just a "plausible mechanism of action", there's actually a *CONFIRMED* clinical outcome and mechanism of action through a large randomized clinical trial in HOPE-3. More details of the HOPE-3 (outside of top-line) was shared at the MDA this week and at this point even the old school RCT requirement regulators would not have much ammo to nit-pick what the data essentially proves in terms of clinical outcomes in Duchenne.
